Mon, 04 Mar 2019 09:36:44 GMT
Biogen to acquire Nightstar Therapeutics for $800M
On Monday, Biogen announced it would acquire Nightstar Therapeutics in the $800M worth cash-deal, amid company's intention to expand its footprint in the gene therapy market.